Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates
Lineage Cell (LCTX) delivered earnings and revenue surprises of 0.00% and -80.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
Here is how C4 Therapeutics, Inc. (CCCC) and Clene Inc. (CLNN) have performed compared to their sector so far this year.
Zacks
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Clene (CLNN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?
Here is how BrightSpring Health Services, Inc. (BTSG) and Clene Inc. (CLNN) have performed compared to their sector so far this year.
Zacks
CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’
Shares of the company rose 8% during regular trading hours but fell after hours following the analyst note.
Stocktwits
Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates
Clene (CLNN) delivered earnings and revenue surprises of +38.00% and -62.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of +15.39% and +0.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Clene (NASDAQ:CLNN) Major Shareholder Sells $34,827.95 in Stock
Clene Inc. (NASDAQ:CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 5,795 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $6.01, for a total value of $34,827.95. Following the sale, the insider directly owned 271,774 shares in the...
MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 72,884 Shares
Clene Inc. (NASDAQ:CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 72,884 shares of Clene stock in a transaction that occurred on Monday, May 4th. The stock was sold at an average...
MarketBeat
Promising Nanotechnology Stocks To Watch Today - May 5th
Onto Innovation, Clene, NVE, and Nano Dimension are the seven Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of companies whose...
MarketBeat

Advertisement|Remove ads.